Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.

ClinicalTrials.gov ID: NCT02425826

Public ClinicalTrials.gov record NCT02425826. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 12:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Multicenter, Randomized, Placebo-controlled, Double-blind, Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate Plaque Psoriasis

Study identification

NCT ID
NCT02425826
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Amgen
Industry
Enrollment
221 participants

Conditions and interventions

Conditions

Interventions

  • Apremilast Drug
  • Placebo Drug
  • Placebo-Apremilast Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 19, 2015
Primary completion
Feb 11, 2016
Completion
Nov 21, 2016
Last update posted
Jun 4, 2023

2015 – 2016

United States locations

U.S. sites
26
U.S. states
16
U.S. cities
24
Facility City State ZIP Site status
UAB at Birmingham - The Kirklin Clinic Birmingham Alabama 35233
Center For Dermatology Fremont California 94538
Dermatology Research Associates Los Angeles California 90045
Blue Harbor Dermatology Newport Beach California 92663
Center for Dermatology and Laser Surgery Sacramento California 95819
East Bay Rheumatology Medical San Leandro California 94578
Tien Q. Nguyen MD Inc Tustin California 92780
UConn Health Center Farmington Connecticut 06030
Dermatology Associates Panama City Florida 32405-4542
USF Health Faculty Office Building-FOB Tampa Florida 33612
Forward Clinical Trials Inc Tampa Florida 33624
Dermatologic Surgery Specialists, P.C. Macon Georgia 31217
Shideler Clinical Research Center Carmel Indiana 46032
Dermatology Specialists, PSC Louisville Kentucky 40202
DermResearch, PLLC Louisville Kentucky 40217
Lawrence Green, MD, LLC Rockville Maryland 20850
Henry Ford Hospital Detroit Michigan 48202
Las Vegas Skin and Cancer Clinics Las Vegas Nevada 89052
Psoriasis Treatment Center of Central New Jersey East Windsor New Jersey 08520
Garden City Dermatology Garden City New York 11530
Sadick Research Group New York New York 10075
Dermatology Associates of Rochester PC Rochester New York 14623
University of Cincinnati Cincinnati Ohio 45267-0501
Dermatology and Laser Center of Charleston Charleston South Carolina 29414
University of Utah School of Medicine Salt Lake City Utah 84132
Dermatology Consultants, Inc. Lynchburg Virginia 24501

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02425826, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 4, 2023 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02425826 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →